When to Buy & S...
Health Care: Drugs
Molecular Insight Pharmaceuticals Inc. (MIPI: OTC)
$0.18 -0.10 | -33.93%
01/27/11 - 03:59 PM ET
385.15K / 337.60K
Vol / Avg. Vol:0.27 / 0.28
Open / Prev. Close:0.17 - 0.27
Today's Range:0.12 - 4.49
52 Wk Range:-90.58%
Performance YTD:TheStreet Rating:
Portfolios with MIPI
- Portfolio NameUser Type
- UserSUPRATRADE HOT STOCKS (BUY ...
- ContributorBarron's Activist Stocks 2-...
- Userlrdjeffrey Portfolio 1
- Userdwilsonnow Portfolio 1
- UserSUPRATRADE TECHNOX-0108071213
- Userindianadan Portfolio 1
- ContributorBiotech Short Squeezes
- UserCenterpoint
- UserGI current
- UserUD
Latest MIPI Headlines from TheStreet
- Biotech Sector Weekly Rewind 12.11.10 | 08:12 am
- Molecular Insight Files for Chapter 11 12.10.10 | 04:12 am
- Biotech Winners: Lexicon Pharma, Exelixis 10.18.10 | 02:10 pm
- Molecular Insight Surges on Trial Results 10.15.10 | 12:10 pm
- Premier Exhibitions, INX: Volume Movers 06.22.10 | 08:06 am
- Ambac, Trico Marine Services: Midday Volume Plays 04.14.10 | 01:04 pm
- Molecular Insights, Empire Resorts: Early Volume Plays 04.13.10 | 08:04 am
- Telular, VirnetX: Early Volume Plays 03.17.10 | 08:03 am
- Venture Capitalists Resist Regulatory Calls 10.15.09 | 08:10 am
- Earnings Roundup: Dish Network, Priceline.com 05.11.09 | 10:05 am
Press Releases for MIPI
Partner Headlines for MIPI
- CORRECTED - CORRECTED-BRIEF-Molecular Insight gets 4th extension on waiver a - Reuters 07.02.10 | 09:07 am
- CORRECTED - CORRECTED-BRIEF-Molecular Insight gets 4th extension on waiver a - Reuters 07.02.10 | 09:07 am
- UPDATE 1-Molecular Insight says cancer drug shows promise - Reuters 06.23.10 | 05:06 pm
- UPDATE 1-Molecular Insight gets second waiver extension - Reuters 05.18.10 | 09:05 am
- UPDATE 1-Molecular Insight gets more time to talk to creditors - Reuters 04.16.10 | 08:04 am
- UPDATE 1-Molecular Insight mid-stage cancer drug trial positive - Reuters 04.12.10 | 05:04 pm
- UPDATE 1-Molecular Insight says gets going concern warning - Reuters 03.16.10 | 05:03 pm
